Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Novartis, Conatus' emricasan fails mid-stage NASH fibrosis trial

firstwordpharmaMarch 23, 2019

Tag: mid-stage NASH , Conatus Pharmaceuticals , fibrosis trial

PharmaSources Customer Service